Industry Sponsorship of Continuing Medical Education

The British Association for Psychopharmacology [BAP], as they do every year, is inviting sponsorship for its Summer Meeting. Here are the packages of “available opportunities” for the 2026 BAP Summer … Continue reading Industry Sponsorship of Continuing Medical Education

Professor David Nutt: “The race is on to get it to market”

A selection of some of the career highlights of Professor David Nutt: BAP Summer Meeting, 1999: BAP Summer Meeting, 2008: BAP Summer Meeting, 2010: BAP Summer Meeting, 2011: BAP Summer … Continue reading Professor David Nutt: “The race is on to get it to market”

“BAPFEST”

Each summer the British Association for Psychopharmacology (BAP) has a Summer Meeting that provides accredited continuing medical education [CME] for psychiatrists and academics. It is hugely popular. A colleague of mine … Continue reading “BAPFEST”

Presidential handover

On Monday 24th July 2018 the Presidency of the British Association for Psychopharmacology was handed over to Professor Allan Young: Professor Allan Young was formerly Chair of the Royal College … Continue reading Presidential handover

“FULLY BOOKED”

I was recently telling a colleague of mine about my campaign for a Sunshine Act for Scotland. My colleague had noticed this recent interview as published in the BMJ: I … Continue reading “FULLY BOOKED”

Rising stars: British Association of Psychopharmacology

I submitted a rapid response to the BMJ last September after viewing galleries of photographs of the British Association of Psychopharmacology (BAP) Summer Meeting of 2016. The BMJ did not … Continue reading Rising stars: British Association of Psychopharmacology

“A robust learning environment for healthcare professionals”

I have recently posted on the promotion of Lurasidone (Latuda) in the UK. This has raised concerns for me about transparency of conflicts of interest for some of the key … Continue reading “A robust learning environment for healthcare professionals”